{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:00:32Z","timestamp":1790719232868,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T00:00:00Z","timestamp":1574553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Portal sinusoidal vascular disease is a presinusoidal cause of portal hypertension (PHT) of unknown etiology, characterized by typical manifestations of PHT (esophageal varices, ascites, portosystemic collaterals), plaquetopenia and splenomegaly with a gradient of portal pressure slightly increased, according to the presinusoidal nature of the PHT. A few cases in the literature have shown a relationship between oxaliplatin and the development of presinusoidal portal hypertension, years after the chemotherapy for colorectal cancer (therefore, different to sinusoidal obstruction syndrome). There are three mechanisms through which oxaliplatin can cause sinusoidal damage: (1) damage at the level of endothelial cells and stimulates the release of free radicals and depletion of glutathione transferase, with altering the integrity of the sinusoidal cells. The damage in the endothelial sinusoidal cells allows to erythrocytes to across into the Diss\u00e9 space and formation of perisinusoidal fibrosis, (2) the appearance of nodular regenerative hyperplasia is favored by the chronic hypoxia of the centrilobular areas and, finally, (3) oxaliplatin can generate an obliteration of the blood capillaries and zones of parenchymal extinction. These three facts can develop, in a minority of cases, the appearance of a presinusoidal increase of portal pressure, which typically appears years after the completion of chemotherapy and sometimes is underdiagnosed until variceal bleeding, ascites or encephalopathy appear. The knowledge of this pathology is essential to be able to perform an early diagnostic and consult to the hepatologist.<\/jats:p>","DOI":"10.3390\/cells8121506","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T03:10:00Z","timestamp":1574651400000},"page":"1506","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It"],"prefix":"10.3390","volume":"8","author":[{"given":"Angela","family":"Puente","sequence":"first","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-9445","authenticated-orcid":false,"given":"Jose Ignacio","family":"Fortea","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Del Pozo","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Huelin","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Cagigal","sequence":"additional","affiliation":[{"name":"Pathology Department, Marqu\u00e9s de Valdecilla University Hospital, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Serrano","sequence":"additional","affiliation":[{"name":"Oncology Department, Marques de Valdecilla, University Hospital, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-484X","authenticated-orcid":false,"given":"Joaquin","family":"Cabezas","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Arias Loste","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Iruzubieta","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-864X","authenticated-orcid":false,"given":"Antonio","family":"Cuadrado","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Llerena","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-741X","authenticated-orcid":false,"given":"Carlos","family":"Lopez","sequence":"additional","affiliation":[{"name":"Oncology Department, Marques de Valdecilla, University Hospital, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"F\u00e1brega","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8248-0172","authenticated-orcid":false,"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Marqu\u00e9s de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s\/n, 39008 Santander, Spain"},{"name":"Health Research Institute Marques de Valdeciila, IDIVAL, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2016). EASL Clinical Practice Guidelines: Vascular diseases of the liver. J. Hepatol., 64, 179\u2013202.","DOI":"10.1016\/j.jhep.2015.07.040"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.gastrohep.2017.03.011","article-title":"Enfermedades vasculares del h\u00edgado. Gu\u00edas Cl\u00ednicas de la Sociedad Catalana de Digestolog\u00eda y de la Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado","volume":"40","author":"Albillos","year":"2017","journal-title":"Gastroenterol. Y. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: A re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: Proposal and description of a novel entity","volume":"4","author":"Rautou","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10620-010-1278-2","article-title":"Non-cirrhotic intrahepatic portal hypertension: Associated gut diseases and prognostic factors","volume":"56","author":"Eapen","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: Natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12072-007-9010-9","article-title":"Noncirrhotic portal fibrosis\/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment","volume":"1","author":"Sarin","year":"2007","journal-title":"Hepatol. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/ajg.2009.165","article-title":"Idiopathic Portal Hypertension in Patients With HIV Infection Treated With Highly Active Antiretroviral Therapy","volume":"104","author":"Chang","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/hep.28499","article-title":"Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension","volume":"63","author":"Vilarinho","year":"2016","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, Fluorouracil, and Leucovorinas Adjuvant Treatment for Colon Cancer","volume":"350","author":"Boni","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/jca.28896","article-title":"Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1040-8428(01)00219-0","article-title":"Particular aspects of platinum compounds used at present in cancer treatment","volume":"42","author":"Desoize","year":"2002","journal-title":"Crit. Rev. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0399-8320(06)73542-4","article-title":"Severe sinusoidal lesions: A serious and overlooked complication of oxaliplatin-containing chemotherapy?","volume":"30","author":"Parent","year":"2006","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastaticcolorectal cancer","volume":"15","author":"Audard","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Lauwers","year":"2010","journal-title":"Histopathology"},{"key":"ref_19","first-page":"211","article-title":"Hepatocyte membrane injury and bleb formation following low dose comfrey toxicity in rats","volume":"74","author":"Yeong","year":"1993","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/toxics3020198","article-title":"Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)","volume":"3","author":"Canta","year":"2015","journal-title":"Toxics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3816\/CCC.2009.n.038","article-title":"Portal Hypertension Associated With Oxaliplatin Administration: Clinical Manifestations of Hepatic Sinusoidal Injury","volume":"8","author":"Slade","year":"2009","journal-title":"Clin. Color. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.clcc.2012.02.002","article-title":"Oxaliplatin-Induced Hepatoportal Sclerosis, Portal Hypertension, and Variceal Bleeding Successfully Treated With Transjugular Intrahepatic Portosystemic Shunt","volume":"11","author":"Lawal","year":"2012","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1245\/s10434-010-1385-5","article-title":"Regenerative nodular hyperplasia of the liver related to chemotherapy: Impact on outcome of liver surgery for colorectal metastases","volume":"18","author":"Wicherts","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2169\/internalmedicine.54.2461","article-title":"Development of nodular regenerative hyperplasia (NRH) with portal hypertension following the administration of oxaliplatin for the recurrence of colon cancer","volume":"54","author":"Takaya","year":"2015","journal-title":"Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"May, D., Djonov, V., Zamir, G., Bala, M., Safadi, R., Sklair-Levy, M., and Keshet, E. (2011). A Transgenic Model for Conditional Induction and Rescue of Portal Hypertension Reveals a Role of VEGF-Mediated Regulation of Sinusoidal Fenestrations. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021478"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","article-title":"Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model","volume":"59","author":"Robinson","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/djx288","article-title":"The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia","volume":"110","author":"Overman","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/hep.30132","article-title":"Idiopathic Portal Hypertension","volume":"68","author":"Baiges","year":"2018","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ajg.2013.11","article-title":"Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension","volume":"108","author":"Seijo","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"20140653","DOI":"10.1259\/bjr.20140653","article-title":"Multimodality imaging of obliterative portal venopathy: What every radiologist should know","volume":"88","author":"Arora","year":"2015","journal-title":"Br. J. Radiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2017.02.003","article-title":"Non-invasive evaluation of portal hypertension using ultrasound elastography","volume":"67","author":"Berzigotti","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0002-9343(76)90323-5","article-title":"Idiopathic portal hypertension","volume":"61","author":"Villeneuve","year":"1976","journal-title":"Am. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12072-017-9801-6","article-title":"Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: A retrospective study of incidental liver biopsies","volume":"11","author":"Zuo","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Da, B.L., Surana, P., Kapuria, D., Vittal, A., Levy, E., Kleiner, D.E., Koh, C., and Heller, T. (2019). Portal Pressure in Noncirrhotic Portal Hypertension: To Measure or Not to Measure. Hepatology, in press.","DOI":"10.1002\/hep.30862"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.dld.2012.05.005","article-title":"Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension","volume":"44","author":"Seijo","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.dld.2019.06.020","article-title":"Incidence of portal hypertension in patients exposed to oxaliplatin","volume":"51","author":"Gioia","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal Efficacy of Endoscopic Variceal Ligation and Propranolol in Preventing Variceal Bleeding in Patients With Noncirrhotic Portal Hypertension","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002709900394","article-title":"Interventional radiologic treatment for idiopathic portal hypertension","volume":"22","author":"Hirota","year":"1999","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/lt.24979","article-title":"Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome","volume":"24","author":"Azzu","year":"2018","journal-title":"Liver Transplant."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/12\/1506\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:37:09Z","timestamp":1760189829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/12\/1506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,24]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cells8121506"],"URL":"https:\/\/doi.org\/10.3390\/cells8121506","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,24]]}}}